Novacyt excites investors with strategic acquisition
Rapid diagnostics testing company Novacyt (NYCT:AIM) has acquired IT-IS International, the exclusive manufacturer of the group's q16 and q32 rapid polymerase chain reaction (PCR) instruments, for £10.1 million in cash. The shares...
15 October 2020